Cytely AB

Based in Sweden, Cytely AB specializes in developing advanced microscopy solutions that enhance the efficiency of biological research and facilitate high-throughput imaging for researchers globally. Cytely AB, founded in 2023, operates from Lund, Sweden, focusing on advanced microscopy solutions. The company has successfully completed 2 deals to date. Recently, it secured USD 3.

000 mn in a Seed funding round led by Ugly Duckling Ventures, with participation from Icebreaker. This funding round represents the total amount raised by the company. Cytely's core offering centers around advanced microscopy solutions designed to enhance the efficiency and effectiveness of biological research. Their flagship product, Smart Microscopy, enables researchers to conduct high-throughput imaging while significantly reducing the time required for data capture and analysis.

This technology allows for the identification of regions of interest in low resolution, followed by high-resolution imaging of critical cellular events, facilitating unprecedented precision in tracking cellular division and responses to various compounds. The primary customers and end-users of Cytely's products include research institutions, pharmaceutical companies, and biotechnological firms engaged in drug discovery and cellular biology studies. The company's products are marketed within key geographical regions, including North America, Europe, and Asia, expanding access to their innovative solutions in diverse research environments. Cytely generates revenue through a structured model that involves the sale of its Smart Microscopy systems and associated software solutions, operating under a subscription-based framework for ongoing software support and updates.

Clients typically engage in direct business transactions for the acquisition of hardware and software packages, which may include customized solutions tailored to specific research needs. Additionally, pricing structures may involve tiered plans based on the scale of use or the integration of advanced features, appealing to both individual researchers and larger institutions. Partnerships with academic and commercial research entities contribute to revenue streams, facilitating collaborative research initiatives. The offerings are designed to provide significant value to clients by accelerating discovery processes and enhancing research capabilities in the life sciences sector.

Cytely AB is strategically focused on expanding its footprint in the microscopy market with plans to launch new product enhancements for Smart Microscopy. The company aims to enter new geographic regions, specifically targeting markets in Asia by the end of 2024. The recent Seed funding of USD 3. 000 mn will be utilized to support product development and market expansion initiatives.